03/03/2025

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

03/03/2025

Mar 3, 2025, 15:28 | Insight
MD Anderson Cancer Center’s Research Highlights
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in…
Mar 3, 2025, 13:56 | Blog
Giuseppe Banna: Pleasure to be invited in Arezzo for the GIOTTO group meeting
Giuseppe Banna, Consultant Medical Oncologist at Portsmouth Hospitals University NHS Trust, shared a post on…
Mar 3, 2025, 13:45 | Science
Samer Al Hadidi: Current State of Evidence on Definitions and Management of High-Risk Multiple Myeloma
Samer Al Hadidi, Assistant professor at UAMS Myeloma Center, shared an article by Bhavesh Mohan…
Mar 3, 2025, 13:43 | Drugs
Zenocutuzumab (Bizengri): What Patients Need to Know
Zenocutuzumab (also known as Zeno or MCLA-128) is a new cancer treatment that targets a…
Mar 3, 2025, 13:38 | Blog
Tom Fleischer: Liquid Biopsy’s Unseen Limitation
Tom Fleischer, Co-founder & CEO at Sequentify, shared a post on LinkedIn: "Liquid Biopsy’s Unseen…
Mar 3, 2025, 13:31 | Blog
Don S. Dizon: A remarkable Breast Cancer Conference in Bangladesh
Don S. Dizon, Director of Women's Cancers at Lifespan Cancer Institute, shared a post on…
Mar 3, 2025, 13:17 | Blog
Gabriel Due: Inspiring local action against cancer - the efforts of NiMSA SCOPH
Gabriel Due, National Director of the Standing Committee on Public Health at Nigerian Medical Students'…
Mar 3, 2025, 13:14 | Blog
Olubukola Ayodele: Healing is not just about treating the disease
Olubukola Ayodele, Consultant Medical Oncologist at the University Hospitals of Leicester NHS Trust, shared a…
Mar 3, 2025, 13:14 | Blog
Aleix Prat: Excited to be attending the JSMO Annual Meeting
Aleix Prat, Director of the Clinic Barcelona Comprehensive Cancer Center, shared a post on LinkedIn:…
Mar 3, 2025, 13:06 | Science
Aakash Desai: Lorlatinib vs. Crizotinib in 1L ALK+ lung cancer
Aakash Desai, Associate Director of Phase 1 and Precision Oncology Program at UAB O’Neal Comprehensive…
All: 79 Posts: 21 - 30
Special Coverage